Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kontoyiannis, Dimitrios P."'
Autor:
Wurster S; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Lewis RE; Clinic of Infectious Diseases, S'Orsola-Malpighi Hospital, and Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Albert ND; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Kontoyiannis DP; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA dkontoyi@mdanderson.org.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2019 Jan 29; Vol. 63 (2). Date of Electronic Publication: 2019 Jan 29 (Print Publication: 2019).
Autor:
Lewis RE; Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA., Pongas GN, Albert N, Ben-Ami R, Walsh TJ, Kontoyiannis DP
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2011 Jan; Vol. 55 (1), pp. 411-3. Date of Electronic Publication: 2010 Oct 18.
Autor:
Ben-Ami R; Department of Infectious Diseases, Infection Control and Employee Health, Unit 1460, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA., Lewis RE, Tarrand J, Leventakos K, Kontoyiannis DP
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2010 Jan; Vol. 54 (1), pp. 484-90. Date of Electronic Publication: 2009 Oct 26.
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
Breakthrough mucormycosis in patients receiving isavuconazole prophylaxis or therapy has been reported. We compared the impact of isavuconazole and voriconazole exposure on the virulence of clinical isolates of Aspergillus fumigatus and different Muc